Disease tolerance and infection pathogenesis age-related tradeoffs in mice.

Summary

This study highlights disease tolerance—limiting host damage without pathogen eradication—as a core survival strategy and shows age-related tradeoffs in mice that shape infection pathogenesis. The work reframes how aging influences outcomes and prioritizes host tissue protection pathways in addition to antimicrobial activity.

Key Findings

• Positions disease tolerance as essential to survive infection by limiting host damage without pathogen killing.
• Demonstrates age-related tradeoffs that modulate infection pathogenesis in mice.
• Motivates therapeutic strategies focusing on host damage control alongside antimicrobial approaches.

Clinical Implications

Although preclinical, these insights support developing therapies that bolster host tolerance (e.g., endothelial protection, metabolic reprogramming) and refining risk stratification in older patients with severe infection or sepsis.

Limitations

• Preclinical murine data may not fully translate to human sepsis
• Limited detail on specific molecular pathways in the abstract

Future Directions

Define molecular effectors of tolerance in aged hosts and test tolerance-enhancing interventions in translational sepsis models.